| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,* University of Virginia Health System, Charlottesville, Virginia; the Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; the Genomics Institute of the Novartis Research Foundation, San Diego, California; The Scripps Research Institute, La Jolla, California; and the Department of Tissue Regeneration and Reconstruction,¶ Division of Oral Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Correspondence: Address correspondence to Henry F. Frierson, Jr., M.D., Department of Pathology, P.O. Box 800214, University of Virginia Health System, Charlottesville, VA 22908-0214. E-mail: hff{at}virginia.edu
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
, the latter of which also was overexpressed in ACC relative to 175 other carcinomas from 10 anatomical sites that we had previously profiled. Additional genes, which were highly expressed in ACC compared to the other carcinomas, included casein kinase 1, epsilon and frizzled-7, both members of the Wnt/ß-catenin signaling pathway. Our study documents for the first time the diverse spectrum of genes overexpressed in ACC and highlights gene products and pathways that in the future might be exploited as therapeutic targets for this cancer, which up until now, has shown limited response to chemotherapeutic approaches.
40%.4 The constellation of genes that are critical for the development and progression of ACC are not known. Furthermore, genes whose expression in ACC is altered relative to those in normal salivary glands and other carcinomas have not yet been compiled. In this study, we used large-scale microarray analysis in an effort to characterize the expression profiles in this salivary gland malignancy, and to specifically identify those genes differentially expressed between ACC and normal salivary gland epithelium. Importantly, we have also compared the compendium of expressed genes in ACC with that for 175 other carcinomas representing the 10 most common types of fatal carcinoma in the United States to determine which genes are uniquely expressed in ACC, and which specific pathways might be exploited for novel therapeutic approaches in this malignancy.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
The use of human tissue samples from the University of Virginia was approved by the UVA Human Investigation Committee, whereas those from M.D. Anderson Cancer Center were approved by the M.D. Anderson Institutional Review Board. The histological distinction of ACC from other salivary gland tumors was made using established criteria,5 whereas the grade of ACC was determined using the criteria of Szanto and colleagues6 in which grade I tumors had no solid component, grade II ACC had <30% solid areas, and grade III cancers contained >30% solid components. Hematoxylin and eosin (H&E)-stained frozen sections of portions of normal submandibular gland from two patients and normal parotid gland from three patients were examined to assess the relative amount of normal epithelium versus stroma and lymphocytes; frozen tissue blocks were then trimmed to enrich for normal salivary gland epithelium, while stroma and lymphocytes were avoided as much as possible. Frozen tumor samples from 15 ACCs that consisted predominantly of neoplastic cells were also selected. It is estimated that trimmed frozen tissues consisted of at least 75% neoplastic cells. Of the 15 patients with ACC, the age range was 26 to 74 years (median, 48 years). Ten patients were men and five were women. Five ACCs arose from a major salivary gland, and 10 arose in minor salivary glands. Seven ACCs were grade I, five were grade II, and three were grade III.
Frozen specimens were stored at -80°C before processing for microarray analysis and uniformly provided high-quality RNA. In duplicate analysis, one normal submandibular gland sample and one ACC specimen were each divided and processed independently. Several milligrams of each sample were sharply dissected and homogenized with a rotary homogenizer in RNeasy lysis buffer (Qiagen, Valencia, CA). RNA was prepared using the RNeasy Mini Kit (Qiagen). Labeled cRNA was then prepared and hybridized to Hu95a Affymetrix oligonucleotide GeneChips (Affymetrix, Santa Clara, CA) as described previously7 and references cited therein.
Cell Culture
ACC3 cells, procured from a human ACC,8 were cultured in RPMI 1640 with 10% fetal calf serum, 1% glutamine, 50 µg/ml streptomycin, and 50 IU/ml penicillin. RNA was extracted and prepared for microarray analysis as above.
Data Analysis
Scanned image files were inspected visually for artifacts and analyzed with GeneChip 3.1 (Affymetrix). Each GeneChip was scaled to an average hybridization intensity of 200, which corresponds to 3 to 5 transcripts per cell.9
Differential expression of genes in normal salivary and ACC specimens was estimated using a hybrid metric10,11
based on equally weighted contributions from the difference of hybridization intensities, the quotient of hybridization intensities, and the result of an unpaired t-test between expression levels in tumor and normal tissues. The genes were scored with respect to each of the three metrics, and then ranked according to the sum of the three scores. Analysis of variance was used to determine whether there were differences in gene expression according to grade of ACC (I, II, or III) or site (major or minor salivary glands). Genes that were differentially expressed in ACC relative to the 10 most common types of fatal carcinoma previously analyzed were determined using recently described molecular classification methods.7
For each gene, a Wilcoxon rank score was successfully calculated for samples in each carcinoma class with the highest mean expression versus samples from all of the other carcinoma classes (implemented in Matlab v6.0). The genes with the lowest P values in each carcinoma class were then ranked based on their predictive accuracy for discriminating one carcinoma class versus all other carcinoma classes by leave-out-one cross-validation using a support vector machine classifier.7
Expression of the ACC classifier genes was compared in ACC samples and normal salivary gland samples using an unpaired t-test to identify those genes with elevated expression in ACC.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis
The ACC3 cell line and frozen tissue specimens from five normal major salivary glands and five ACCs were used for RT-PCR analysis. Three of the ACCs had undergone gene expression profiling, while two had not. H&E-stained frozen sections of the ACCs and normal salivary glands were microdissected to obtain target epithelial populations of 1000 cells each with at least 95% purity for tumor and, also, at least 95% purity for normal gland using a Leica AS LMD (laser microdissection system) (Leica Microsystems Inc., Bannockburn, IL). Each microdissected sample was subjected to RNA isolation by guanidine isothiocyanate buffer extraction, phenol/chloroform extraction, and alcohol precipitation (Micro RNA isolation kit; Stratagene, La Jolla, CA). The RNA samples were treated with 20 U of RNase-free DNase (Stratagene) for 1 hour at 37°C, followed by phenol/chloroform extraction and alcohol precipitation. First strand cDNA was synthesized in 20-µl reactions using random hexamer primers and Superscript II (Life Technologies, Inc., Gaithersburg, MD). Reactions were incubated on ice for 5 minutes, then at ambient temperature for 5 minutes, then at 42°C for 2 hours. Ten µL of the cDNA solutions were placed in 50-µL PCR containing 2 U of Taq polymerase. Sox 4 primers (5'-GCGGCGGGAGCAGCAAC-3', 5'-GGAGCCGCAGCTCTTTTTC-3', 92-bp product) were at 1 µmol/L final concentration and ß2-microglobulin primers (5'-ATTCACCCCCACTGAAAAAG-3', 5'-TCCATGATGCTGCTTACATG-3', 106-bp product) were at 0.1 µmol/L final concentration. Cycling conditions were: 40 cycles of 94°C for 30 seconds, 55°C for 60 seconds, and 72°C for 30 seconds. PCR products were visualized by agarose gel electrophoresis, ethidium bromide staining, and UV light illumination. Relative RNA concentration was determined by image capture and analysis on an AlphaImager workstation (
Innotech, San Leandro, CA).
Immunohistochemistry
Deparaffinized zinc formalin-fixed, paraffin-embedded tissue sections of normal parotid and submandibular glands, ACC3, and three ACCs that were analyzed for global gene expression were immunostained using antibodies to keratin 17, cyclin D1, collagen IV, laminin, and ß-catenin. An independent set of 10 ACCs whose transcripts were not profiled was also immunostained with antibodies to cyclin D1, collagen IV, laminin, and ß-catenin to assess the frequency of protein expression in these tumors. Slides were placed in citrate buffer and heated in a microwave oven for 20 minutes before staining for keratin 17, cyclin D1, and ß-catenin. Predigestion with protease was used for anti-collagen IV, while trypsin was used for anti-laminin. The primary antibodies selected included a mouse monoclonal antibody to keratin 17 (clone Ks17.E3, 1:50 dilution; Research Diagnostics, Flanders, NJ), a rabbit polyclonal antibody to cyclin D1 (1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA), a mouse monoclonal antibody to collagen IV (clone CIV22, 1:50 dilution; DAKO, Glostrup, Denmark), a mouse monoclonal antibody to ß-catenin (clone 14, 1:200 dilution; BD Biosciences, San Diego, CA), and a mouse monoclonal antibody to laminin (clone LAM-89; 1:50 dilution; Novocastra, Newcastle, UK). After incubation with the primary antibody and the addition of the biotinylated secondary antibody, avidin-biotin immunoperoxidase was applied. Diaminobenzidine was used as the chromogen. Sections were then counterstained with hematoxylin. For the antibodies to keratin 17, cyclin D1, and laminin, immunoreactivity was scored semiquantitatively as negative, 1+ (<1% cells positive), 2+ (1 to 10% cells), 3+ (11 to 25% cells), or 4+ (>25% cells).
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
The expression levels of genes in normal and ACC tissue samples and one ACC-derived cell line (ACC3) were determined by hybridization of RNA to oligonucleotide microarrays comprising 12,533 probe sets representing 8920 unique human genes (listed by RefSeq numbers and Unigene ID). In total we hybridized 23 RNA samples from five normal major salivary glands, 15 ACCs, and one ACC cell line (ACC3). One of the normal salivary gland samples and one ACC sample were divided into approximately equal proportions, processed, and hybridized in duplicate to assess reproducibility of the experiments. Genes that showed the largest variation across the samples were selected to group them based on their similarities in expression levels.12
With a SD cut-off of 500, 1038 genes were clustered. Using this approach, a dendrogram was constructed, and showed that the samples of normal salivary gland in duplicate were highly correlated, as were the duplicate samples of one ACC (Figure 1)
. Within the dendrogram, the normal submandibular and parotid glands clustered near each other but separately, whereas the 15 ACCs clustered into three groups. No overt differences were seen for patient age, sex, or site of tumor origin between the three clustered groups of tumors. All three grade III ACCs clustered in the largest group of tumors, whereas all ACCs in the smallest group (n = 3) were grade I; three other grade I ACCs were in the largest clustered group, however, and one other was in the third group. Analysis of the ACC3 cell line revealed that it clustered with the largest group of ACCs from patient samples.
|
As normal major salivary glands and ACCs could be distinguished by their gene expression profile, we used a metric method to rank genes with the largest and most uniform differences in expression between the two sets of tissue samples (Table 1)
. For the 30 genes with the highest ranked differential over-expression in ACL, the fold level ranged from 3.5 to 78 (mean, 13.9; median, 9.2).
|
and , and the NGFI-A binding protein 1. Functionally, a group of genes encoding extracellular matrix proteins and basement membrane components such as versican, biglycan, laminin-ß1, and type IV collagen-1 were also identified. Indeed, the highest fold differences between ACC and normal major salivary glands were seen for laminin (78-fold) and versican (29-fold). Overexpressed genes in ACC encoding cytoskeletal or associated proteins included keratin 17, -tubulin (b1), and filamin A. Genes encoding membrane proteins were observed at elevated levels in ACC, and included macrophage erythroblast attacher, FAT tumor suppressor, transmembrane 4 superfamily member 1, Notch 3, Homer neuronal immediate early gene 3, GABA A and B receptors, and immunoglobulin superfamily member 3.
Overexpression of Sox4 transcripts in ACC relative to normal parotid and submandibular glands was validated by RT-PCR using laser-microdissected cells (Figure 2)
. This was observed for each of the five ACCs as well as for ACC3.
|
. The 10 ACCs not profiled showed 2+ to 4+ immunoreactivity for cyclin D1. Immunostaining with anti-collagen IV for the three ACCs that were profiled revealed very thick bands of positivity around nests, ducts, and the inner lining of pseudolumens as well as some conspicuous (often intense) immunoreactivity within the hyaline material of the pseudolumens (Figure 3)
. Each of the additional 10 ACCs also showed strong immunopositivity for collagen IV in the same distribution. Collagen IV was inconspicuous or, at most, appeared as a very thin line around normal salivary ducts and, less often, around acini. Similarly, staining for laminin was inconspicuous or sometimes focal around normal salivary ducts and acini. In the three ACCs whose transcripts were profiled, there was 4+ immunoreactivity in tumor cells as well as staining immediately surrounding nests, lining pseudocystic spaces, and sometimes within hyaline material (Figure 3)
. Seven of the nine additional ACCs also showed 4+ immunopositivity. Approximately 10% of the ACC3 cells were immunopositive for laminin.
|
40 had variable differences relative to tumor location in major or minor salivary glands (P < 0.01). (These lists of genes will be made available on request.) Approximately 60% of the 100 genes that showed the highest levels of expression in the 15 ACCs relative to the normal salivary glands also showed high levels of expression in the ACC3 cell line. Among these genes were Sox4, transmembrane 4 superfamily member 1, keratin 17, jagged 1, filamin A, GABA-B receptor 1, and NGFI-A binding protein 1.
We also identified many genes that were significantly down-regulated in ACC relative to normal salivary glands (Table 2)
. Of the most highly ranked down-regulated genes were those encoding secretory proteins such as histatin 3, amylase, fucosyltransferase 6, carbonic anhydrase VI, lactoperoxidase, statherin, and salivary proline-rich proteins.
|
To identify genes whose overexpression may be characteristic of ACC relative to other more common carcinomas, we used a recently described molecular classification method that seeks classifier genes that can predict the anatomical origin or tumor type of a blinded tumor sample by cross-validation or independent testing.7
Genes expressed in ACC were compared with those from 175 other carcinomas from 10 different anatomical sites (lung, breast, prostate, bladder/ureter, liver, kidney, esophagus and stomach, colorectum, ovary, and pancreas).7
Using this approach, we identified 21 genes that could accurately classify 13 of the 15 ACC samples with high confidence (Figure 4A)
. We have previously shown that such classifier genes typically represent features of the tissues from which the tumors arise, as well as features of the carcinomas from these tissues. Thus, we compared the expression of the 21 classifier genes in ACC with the normal major salivary glands (Figure 4B)
. The differential expression of these genes was generally highly significant (t-test; 8.4 x 10-3 to 1.8 x 10-8 with the exception for Sox10), implying that most of these classifiers represent genes expressed at high levels in ACC rather than the normal salivary glands from which they arose. Four of these genes (AP-2, macrophage erythroblast attacher, versican, and laminin-ß1) were among the most highly ranked genes in ACC compared with normal major salivary glands. Known genes that were the most specific for ACC relative to the other carcinomas included versican, TGF-ß type III receptor, and c-myb. Two other highly expressed genes included casein kinase 1, epsilon and frizzled-7, members of the Wnt/ß-catenin signal transduction pathway. Immunostaining for ß-catenin in 13 ACCs (3 whose transcripts were profiled and 10 others) revealed variable immunopositivity limited to the cytoplasmic membrane; no nuclear or cytoplasmic immunoreactivity was observed.
|
, versican, frizzled-7, and laminin-ß1, genes that showed important differential expression for the other ACCs compared with the cancers from the 10 other anatomical sites. |
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
1 in ACC relative to normal major salivary glands. The most significantly overexpressed gene in ACC relative to the normal major salivary glands was SOX4, which encodes a transcription factor expressed in a wide variety of tissues in mice, and has functional importance in heart, brain, the reproductive system, and B-cell development.20-23 The SOX gene family members have a highly conserved HMG-domain responsible for sequence-specific DNA binding.24 In serial analysis of gene expression, SOX4 was overexpressed in normal mammary epithelium relative to ductal carcinoma in situ and invasive carcinoma of the breast.25 Some breast cancer cell lines, however, have been shown to highly express SOX4, which is increased by progestins.26 Although elevated expression of SOX4 was not unique to ACC, the genes that it transcribes and its role in tumor development or progression requires additional study.
The genes encoding transcription factors AP-2 and AP-2 were also overexpressed in ACC. The AP-2 family members have been reported to regulate the expression of genes required for murine development of several tissues such as neural crest and skin.27,28
Genes regulated by AP-2 are important in numerous biological functions and include, among others, estrogen receptor, keratinocyte-specific genes, and c-kit.29-32
KIT protein has been found to be overexpressed in many ACCs.33
Interestingly, versican34
and biglycan35
have binding sites for AP-2 suggesting a direct correlation between expression levels of these genes and AP-2. Both AP-2 and AP-2 are reported to be overexpressed in breast carcinoma.36
Although we noted that AP-2 was modestly expressed in our breast cancers, there was on average a threefold increase in expression in ACC compared with the mammary tumors.
Genes encoding transmembrane proteins highly expressed in ACC included FAT tumor suppressor and transmembrane 4 superfamily member 1. The former contains 34 cadherin repeats, is expressed in many types of epithelium, and encodes a putative tumor suppressor protein.37-39 FAT tumor suppressor has been shown to be down-regulated in metastatic prostate cancer.40 The importance of its overexpression in ACC, therefore, is interesting and the functional consequences of its overexpression require additional study. Transmembrane 4 superfamily member 1, also known as tumor-associated antigen L6, encodes a cell surface protein implicated in cell growth. It is highly expressed in several carcinomas including those of the lung, breast, ovary, and colon,41 and has been suggested as a target for monoclonal antibody therapy.
Genes encoding secreted proteins highly expressed in normal parotid and submandibular glands relative to ACC are those indicative of acinar cell differentiation. These genes such as amylase, carbonic anhydrase VI, and salivary proline-rich proteins, among others, would be predicted to be expressed in salivary gland neoplasms having acinar differentiation such as acinic cell carcinoma.
Approximately 60% of the 100 genes overexpressed in ACC relative to normal major salivary glands were also overexpressed in the ACC3 cell line. These genes included Sox 4, keratin 17, transmembrane 4 superfamily member 1, and laminin. ACC3 has been shown to secrete large quantities of basement membrane proteins including laminin and type 4 collagen in vitro as well as in mice.42,43 The overlap in overexpressed genes in human ACC and ACC3 would suggest that ACC3 is a valid model system for the study of molecular alterations that might be important in human ACC carcinogenesis.
Thirteen of 15 ACCs had profiles distinctly different from 175 other carcinomas from 10 anatomical sites, enabling their classification by cross-validation with high confidence. Both versican and AP-2 were among the top ranked classifier genes in ACC. The former was either absent or lowly expressed in carcinomas other than ACC, whereas AP-2 was consistently expressed at modest levels among many of the 175 other tumors, but showed the highest statistical difference in ACC relative to the other tumors and the normal major salivary glands.
Two of the most highly ranked classifier genes in ACC included components of the Wnt/ß-catenin signal transduction pathway. Frizzled-7, expressed normally in various adult and fetal tissues, encodes a receptor for WNT proteins and may down-regulate the function of APC and therefore promote ß-catenin signaling.44
The protein product of casein kinase 1, 
,45
expressed in multiple human cell lines, complexes with axin and perhaps other components of the Wnt system; its overexpression stabilizes ß-catenin, thereby promoting the transcription of ß-catenin-dependent genes.46
Using immunohistochemistry, we noted variable cytoplasmic membrane immunopositivity for ß-catenin in ACC, but no nuclear or cytoplasmic staining. This finding would suggest that the Wnt/ß-catenin pathway is not overtly dysregulated in ACC, as it is, for example, in colorectal carcinomas in which a pathway member is typically mutated leading to translocation of ß-catenin to the nucleus.
Another classifier gene in ACC, nuclear factor I/B, encodes a transcription factor that is important in tissue-specific gene expression during growth and differentiation.47,48
Nuclear factor I/B, located at 9p24, has been found to be involved in a hybrid transcript with HMGIC in two pleomorphic adenomas of salivary gland,49
perhaps extending the importance of this gene in ACC. In that regard, it is of note that 30% of ACCs have cytogenetic evidence of translocations involving 9p13-23.50
Whether nuclear factor I/B is a target of this translocation or is dysregulated by other means in ACC is currently unknown. In addition, c-myb, located at 6q22, was also overexpressd in ACC. Interestingly, 6q is usually the translocation partner with 9p in ACC.
Our study has elucidated those genes that are overexpressed in ACC relative to normal major salivary glands. We have also identified certain genes that are selectively overexpressed in ACC relative to 10 other types of carcinoma. Among the overexpressed genes are several that encode transcription factors, extracellular matrix components, and signal transduction pathway members. The information derived from such global transcription profiling offers clues as to which regulatory pathways should be first targeted for further study regarding their effects on tumor growth and behavior. The identification of genes overexpressed in ACC may suggest new therapeutic targets for this carcinoma, which up until now, has primarily been attacked by the surgical approach, and which when it becomes metastatic cannot be treated with complete success.
|
Footnotes |
|---|
Accepted for publication June 28, 2002.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  X. Pan, J. Zhao, W.-N. Zhang, H.-Y. Li, R. Mu, T. Zhou, H.-Y. Zhang, W.-L. Gong, M. Yu, J.-H. Man, et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function PNAS, March 10, 2009; 106(10): 3788 - 3793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Rao, D. Roberts, Y.-J. Zhao, D. Bell, C. P. Harris, R. S. Weber, and A. K. El-Naggar Deletion of 1p32-p36 Is the Most Frequent Genetic Change and Poor Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands Clin. Cancer Res., August 15, 2008; 14(16): 5181 - 5187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. de Bont, J. M. Kros, M. M.C.J. Passier, R. E. Reddingius, P. A.E. S. Smitt, T. M. Luider, M. L. d. Boer, and R. Pieters Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis Neuro-oncol, January 1, 2008; 10(5): 648 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Queimado, D. Obeso, M. D. Hatfield, Y. Yang, D. M. Thompson, and A. M.C. Reis Dysregulation of Wnt Pathway Components in Human Salivary Gland Tumors Arch Otolaryngol Head Neck Surg, January 1, 2008; 134(1): 94 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Leong, K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, and A. Karsan Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin J. Exp. Med., November 26, 2007; 204(12): 2935 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Vekony, B. Ylstra, S. M. Wilting, G. A. Meijer, M. A. van de Wiel, C. R. Leemans, I. van der Waal, and E. Bloemena DNA Copy Number Gains at Loci of Growth Factors and Their Receptors in Salivary Gland Adenoid Cystic Carcinoma Clin. Cancer Res., June 1, 2007; 13(11): 3133 - 3139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L.M. Boylan, M. A. Gosse, S. E. Staggs, S. Janz, S. Grindle, G. S. Kansas, and B. G. Van Ness A Transgenic Mouse Model of Plasma Cell Malignancy Shows Phenotypic, Cytogenetic, and Gene Expression Heterogeneity Similar to Human Multiple Myeloma Cancer Res., May 1, 2007; 67(9): 4069 - 4078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Bustos, A. Ferrarese, A. Venerando, O. Marin, J. E. Allende, and L. A. Pinna The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1 PNAS, December 26, 2006; 103(52): 19725 - 19730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aaboe, K. Birkenkamp-Demtroder, C. Wiuf, F. B. Sorensen, T. Thykjaer, G. Sauter, K. M.-E. Jensen, L. Dyrskjot, and T. Orntoft SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization. Cancer Res., April 1, 2006; 66(7): 3434 - 3442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Du, S. E. Spence, N. A. Jenkins, and N. G. Copeland Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis Blood, October 1, 2005; 106(7): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reichling, K. H. Goss, D. J. Carson, R. W. Holdcraft, C. Ley-Ebert, D. Witte, B. J. Aronow, and J. Groden Transcriptional Profiles of Intestinal Tumors in ApcMin Mice are Unique from those of Embryonic Intestine and Identify Novel Gene Targets Dysregulated in Human Colorectal Tumors Cancer Res., January 1, 2005; 65(1): 166 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Maruya, H.-W. Kim, R. S. Weber, J. J. Lee, M. Kies, M. A. Luna, J. G. Batsakis, and A. K. El-Naggar Gene Expression Screening of Salivary Gland Neoplasms: Molecular Markers of Potential Histogenetic and Clinical Significance J. Mol. Diagn., August 1, 2004; 6(3): 180 - 190. [Abstract] [Full Text]
|
|
|
|
|
|
M. Urosevic, P. A. Oberholzer, T. Maier, J. Hafner, E. Laine, H. Slade, B. Benninghoff, G. Burg, and R. Dummer Imiquimod Treatment Induces Expression of Opioid Growth Factor Receptor: A Novel Tumor Antigen Induced by Interferon-{alpha}? Clin. Cancer Res., August 1, 2004; 10(15): 4959 - 4970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression PNAS, June 22, 2004; 101(25): 9309 - 9314. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
